Public Policy Priorities & Regulation
Dialogue on enabling frameworks, regulatory pathways and conditions for responsible biotechnology development
CABA aims to support practical dialogue on biotechnology policy, regulation and sector development by connecting relevant scientific, industry and institutional expertise
Dialogue on enabling frameworks, regulatory pathways and conditions for responsible biotechnology development
CABA develops evidence-based institutional perspectives through analysis, expert consultation and dialogue with relevant stakeholders
Scientific, industry and professional expertise supports the assessment of biotechnology topics, initiatives and regulatory questions
Analytical notes translate complex scientific, market and regulatory developments into clear context for decision-makers and ecosystem participants
Regulatory monitoring helps identify developments that affect biotechnology research, commercialization, investment, production and market access
CABA supports informed dialogue on regulatory initiatives by connecting government, science, industry and professional expertise
CABA creates a professional interface between science, industry, the expert community and public policy, supporting analysis of regulatory initiatives and evidence-based recommendations
Expert work is based on evidence, professional independence, competence, transparency, conflict-of-interest management and multidisciplinary, intersectoral assessment. The framework includes expert eligibility criteria, an expert register and an assessment methodology.
The institutional process covers preparation, coordination and approval of expert conclusions and official CABA positions. Outputs may include recommendations, analytical notes, regulatory reviews, analytical reports and industry reviews.